Corrigendum: Coexpression of HHLA2 and PD-L1 on tumor cells independently predicts the survival of spinal chordoma patients

Front Immunol. 2023 Apr 14:14:1194064. doi: 10.3389/fimmu.2023.1194064. eCollection 2023.

Authors

Chao Xia^{1

2}, Wei Huang¹, Yun-Liang Chen³, Hai-Bin Fu², Ming Tang², Tao-Lan Zhang², Jing Li⁴, Guo-Hua Lv⁴, Yi-Guo Yan², Zhi-Hua Ouyang², Nvzhao Yao², Cheng Wang², Ming-Xiang Zou²

Affiliations

¹ The First Affiliated Hospital, Health Management Center, Hengyang Medical School, University of South China, Hengyang, China.
² Department of Spine Surgery, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, China.
³ Shenzhen Audaque Data Technology Co., Ltd., Shenzhen, China.
⁴ Department of Spine Surgery, The Second Xiangya Hospital, Central South University, Changsha, China.

Abstract

[This corrects the article DOI: 10.3389/fimmu.2021.797407.].

Keywords: HHLA2; PD-L1; immune checkpoint molecules; quantitative immunofluorescence; spinal chordoma; tumor infiltrating lymphocytes.

Copyright © 2023 Xia, Huang, Chen, Fu, Tang, Zhang, Li, Lv, Yan, Ouyang, Yao, Wang and Zou.

Publication types

Published Erratum